Acadia Pharmaceuticals Inc (ACAD)
CapEx to Revenue
3.34%
Quarterly · Period ending:
ACAD CapEx to Revenue
Latest reported3.34%period ending
Latest reported3.34%period ending
ACAD Quarterly CapEx/Revenue (0.00% → 3.34%)
Latest values, visible window
High-resolution chart · PNG
ACAD capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 3.3449% | |
| 1.9443% | |
| 1.4103% | |
| 0.1393% | |
| 37.2463% | |
| 40.4548% | |
| 0.1745% | |
| 0.028% | |
| 0% | |
| 0% | |
| 0% | |
| 0.0236% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.0008% | |
| 0% | |
| 0.0391% | |
| 1.0098% | |
| 1.652% | |
| 1.4273% | |
| 2.6639% | |
| 1.037% | |
| 0.2105% | |
| 0.0846% | |
| 0.024% | |
| 1.3056% | |
| 0.9568% | |
| 1.7408% | |
| 0.2015% | |
| 0.9168% | |
| 0.0161% | |
| 0.1574% | |
| 0.8663% | |
| 3.1728% | |
| 2.0816% | |
| 8.9218% | |
| 8,845.3608% | |
| 5,175% | |
| 1,723.5294% | |
| 476.9231% | |
| 67,400% | |
| 24,700% | |
| 200% | |
| 533.3333% | |
| 0% | |
| 20% | |
| 345.9459% | |
| 177.9167% | |
| 16.408% | |
| 0% | |
| 0.7895% | |
| 0% | |
| 0% | |
| 0% | |
| 0.5102% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.961% | |
| 0.6982% | |
| 0.1099% | |
| 1.3369% | |
| 2.1538% | |
| 23.7589% | |
| 42.3729% | |
| 9.5533% | |
| 4.043% | |
| 8.0225% | |
| 6.0827% | |
| 3.5714% | |
| 38.3531% | |
| 21.6161% | |
| 38.6497% | |
| 7.8439% | |
| 9.4351% | |
| 8.4742% | |
| 15.4697% | |
| 3.9136% | |
| 18.4696% | |
| 5.3627% | |
| 25.4603% | |
| 4.5243% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |